In his weekly clinical update, Dr. Griffin discusses the potential for recurrent Mpox outbreaks among gay, bisexual, and other men who have sex with men, association between SARS-CoV-2 variants and frequency of acute symptoms, prospective study of key correlates for household transmission of SARS-CoV-2, Pfizer’s PAXLOVID™ receiving FDA approval for adult patients at high risk of progression to severe COVID-19, efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalized with COVID-19, development of a definition of postacute sequelae of SARS-CoV-2 infection, COVID-19 and risk for mental disorders among adults in Denmark, risk of new post-COVID mental disorders higher only in older patients.
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Potential for recurrent Mpox outbreaks among men who have sex with men (CDC)
- Association between SARS-CoV-2 variants and frequency of acute symptoms (OFID)
- Key correlates for household transmission of SARS-CoV-2 (OFID)
- PAXLOVID receiving FDA approval for patients at high risk of severe COVID-19 (Pfizer)
- Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients with COVID-19 (The Lancet)
- Development of a definition of postacute sequelae of SARS-CoV-2 (JAMA)
- COVID-19 and risk for mental disorders among adults in Denmark (JAMA)
- Risk of new post-COVID mental disorders higher only in older patients (CIDRAP)
- Contribute to our FIMRC fundraiser at PWB
- Letters read on TWiV 1012
- Dr. Griffin’s COVID treatment summary (pdf)
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv